Unanticipated Consequences of DNA Hypomethylation; Loss and Gain of Polycomb Mediated Transcription Repression in Somatic Cells|
Monday, April 01, 2013
By genome-wide mapping of the Polycomb Repressive Complex 2 (PRC2)-signature histone mark, H3K27me3, in DNA methylation-deficient mouse somatic cells, the Meehan lab shows that loss of DNA methylation is coincident with widespread H3K27me3 redistribution.
Wyss Institute Awarded DARPA Contract to Further Advance Sepsis Therapeutic Device
Thursday, March 28, 2013
DARPA gives award to further advance a blood-cleansing technology and help accelerate its translation to humans as a new type of sepsis therapy.
Designing Interlocking Building Blocks to Create Complex Tissues
Wednesday, March 20, 2013
New technique enables more precise design of tissue architecture.
Epigem and Dolomite Join Forces
Wednesday, March 13, 2013
Both Companies announces collaboration in the design and manufacture of microfluidic devices.
Cooperation Between Micronit and Fluigent
Wednesday, March 06, 2013
Both Companies enters into a co-promotion agreement to promote each other’s products.
Harvard Wyss Institute's Lung-on-a-Chip Wins Prize for Potentially Reducing need for Animal Testing
Thursday, February 28, 2013
UK award recognition validates US teams' approach to revolutionize drug development.
Dolomite Celebrates a Successful 2012
Tuesday, February 12, 2013
Microfluidics company Dolomite has reported an exceptional 20% year-on-year growth in 2012.
Trinean to In-License PerkinElmer Technology
Monday, February 04, 2013
Trinean has announced that it has entered into a license agreement with PerkinElmer to license certain microfluidics technology in the field of UV-VIS quantification analysis.
Gyros AB Appoints Dr. Claus Braestrup to the Board of Directors
Monday, January 28, 2013
Dr. Braestrup is a member of the Board of Directors of Bavarian Nordic A/S, Chairman of the Board of Probiodrug AG and a member of the Boards of Santaris Pharma A/S and Evolva Holding SA.